The Cost of Cancer Treatment Impacts Prescription Drug Adherence

A recent study found that patients with a history of cancer are more prone to change their prescription drug regimen because of the cost.
The rising cost of cancer treatment is negatively affecting prescription drug adherence, according to a recent study conducted by researchers at the American Cancer Society and published in the journal Cancer.
Patients with a history of cancer were more likely to stop or switch their treatment for financial reasons than patients with other diseases, according to the study, which used data from the National Health Interview Survey. Further, nonelderly cancer survivors were more likely than elderly cancer survivors to alter or stop their treatment, and nonelderly people with high deductibles are more likely to ask their physicians for a lower price than those who have a lower deductible.
Rising deductibles, copayments, co-insurance and tiered drug formularies all contribute to the increasing percentage of cancer care cost that patients must now pay for out of pocket. This can affect survivors’ overall wellbeing, lead to poorer treatment choices, have a negative effect on outcomes and cause higher medical expenses down the line, according to the study.
“I would encourage patients to discuss their financial concerns with their care providers when making treatment decisions,” Xuesong Han, Ph.D., strategic director, Health Policy and Healthcare Delivery Research at the American Cancer Society, and author on the study said in an interview with CURE.  
The study found that 31.6 percent of recently diagnosed survivors (those who were diagnosed within the past two years) and 27.9 percent of patients previously diagnosed (two years ago or longer) reported a change in their prescription due to financial reasons. This is compared to 21.4 percent of people without a history of cancer.
“Nonelderly cancer survivors are particularly vulnerable to the risk of changing their prescription drug use for financial reasons, which may be explained in part by the complex relationship between employment and insurance coverage,” the article says.
While younger working-age patients may depend on their employment for insurance, elderly patients are typically covered under Medicare, which is likely a reason for their being less inclined to stop treatment due to money problems, the study says.

Talk about this article with other patients, caregivers, and advocates in the General Financial Topics CURE discussion group.
Special Feature
Share Your Art
Related Articles
I Am More Than My Cancer
Sometimes we can be regarded as being obsessed with cancer, but every single cancer survivor is more than that, and hold important roles in our lives to play.
Do Genes and Gender Play a Role in Chemotherapy-Related Fatigue?
Genetics may play a role in chemotherapy-related fatigue, according to a recent study.
Complementary Therapies for Cancer Treatment Are Coming of Age
Nonmedical treatments offering physical and psychosocial relief are gaining respect in the medical community.
Related Videos
Preserving Eyebrows During Chemotherapy Treatment
Renata Marie Vestevich, founder and developer of Essential Eyebrow Solution (EES), discusses how this topical solution may be able to help patients keep their eyebrow hair while undergoing chemotherapy.
Does Age Affect Cancer Genomics?
Garrett Frampton, associate director of Cancer Genomics at Foundation Medicine, discusses recent research about genetic mutations that are more common in certain age groups.  
Facing Advanced Cancer's Struggles With CALM
Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.
//For side ad protocol